erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
.
"this should not have happened and should never be allowed to happen again to another vulnerable person or their family.
.
.
suicidal thoughts, attempts on the rise among young people: 'it's a critical public-health crisis right now'
.
.
�now we know the astonishing truth that some patients are waiting a year or more just to get treatment. it�s simply not good enough.�
.